Signaling Pathway
Etevritamab is a monoclonal antibody designed to target both CD3E and EGFR. This dual-specificity enables it to engage mechanisms related to T-cell activation and tumor cell inhibition, making it a valuable tool for research in immunotherapy and oncology. Etevritamab may be utilized in studies aiming to elucidate the pathways of immune response modulation and tumor growth suppression.
重要通知：仅供研究使用。我们不向患者销售。
| Discription | Etevritamab is a monoclonal antibody designed to target both CD3E and EGFR. This dual-specificity enables it to engage mechanisms related to T-cell activation and tumor cell inhibition, making it a valuable tool for research in immunotherapy and oncology. Etevritamab may be utilized in studies aiming to elucidate the pathways of immune response modulation and tumor growth suppression. |
||
|---|---|---|---|
| Targets |
|
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
